Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. Five-fluorouracil (5FU) remains the single most effective treatment for advanced disease, despite a response rate of only 20%. Herein, we show that the antioxidants pyrrolidinedithiocarbamate and vitamin E induce apoptosis in CRC Cells. This effect is mediated by induction of p21WAF1/CIP1, a powerful inhibitor of the Cell cycle, through a mechanism involving C/EBPβ (a member of the CCAAT/enhancer binding protein family of transcription factors), independent of p53. Antioxidants significantly enhance CRC tumor growth inhibition by cytotoxic chemotherapy in vitro (5FU and doxorubicin) and in vivo (5FU). Thus, chemotherapeutic agents administered in the presence of antioxidants may provide a novel therapy for colorectal cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Parker, S.L. et al. Cancer statistics. CA Cancer J. Clin. 46, 5–27 (1996).

    Article  CAS  Google Scholar 

  2. Symonds, H. et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703–711 (1994)

    Article  CAS  Google Scholar 

  3. Advanced Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J. Clin. Oncol. 10, 896–903 (1992).

  4. Lowe, S.W., Ruley, H.E., Jacks, T. & Housman, D.E. Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957–967 (1993).

    Article  CAS  Google Scholar 

  5. Lowe, S.W. et al. p53 status and the efficacy of cancer therapy in vivo. Science 266, 807–810 (1994).

    Article  CAS  Google Scholar 

  6. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. p53 mutations in human cancers. Science 253, 49–53 (1991).

    Article  CAS  Google Scholar 

  7. Levine, A., Momand, J. & Finlay, C.A. p53 tumor suppressor gene. Nature 351, 453–456 (1991).

    Article  CAS  Google Scholar 

  8. Boyle, P., Zaridze, D.G. & Smans, M. Descriptive epidemiology of colorectal cancer. Int. J. Cancer 36, 9–18 (1985).

    Article  CAS  Google Scholar 

  9. Byers, T. & Perry, G. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu. Rev. Nutr. 12, 139–159 (1992).

    Article  CAS  Google Scholar 

  10. Stone, W.L. & Papas, A.M. Tocopherols and the etiology of colon cancer. J. Norl. Cancer Inst. 89, 1006–1014 (1997).

    Article  CAS  Google Scholar 

  11. Greenwald, P., Kelloff, G.J., Burch-Whitman, C. & Kramer, B.S. Chemoprevention. CA Cancer. J. Clin. 45, 31–49 (1995).

    Article  CAS  Google Scholar 

  12. Turley, J.M. et al. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: Role for transforming growth factor β. Cell. Growth Differ. 6, 655–663 (1995).

    CAS  PubMed  Google Scholar 

  13. Tsai, J.C. et al. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetyl-cysteine in vascular smooth muscle cells. J. Biol. Chem. 271, 3667–3670 (1996).

    Article  CAS  Google Scholar 

  14. Church, S.L. et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Notl. Acad. Sci. USA 90, 3313–3317 (1993).

    Google Scholar 

  15. Rautalahti, M. & Antioxidants and carcinogenesis. Ann. Med. 25, 435–441 (1993).

    Google Scholar 

  16. Irani, K. et al. Mitogenic signaling mediated by oxidants in ras-transformed fibrob-lasts. Science 275, 1649–1652 (1997).

    Article  CAS  Google Scholar 

  17. Herrmann, R. Biochemical modulation of 5-fluorouracil. Cancer Treat. Rev. 17, 51–55 (1990).

    Article  CAS  Google Scholar 

  18. Cummings, J. Anderson, L., Willmott, N. & Smyth, J.F. The molecular pharmacology of doxorubicin in vivo. Eur. J. Cancer 27, 532–535 (1991).

    Article  CAS  Google Scholar 

  19. Peters, G.J. et al. Thymidylate synthase and drug resistance. Eur. J. Concer 31, 1299–1305 (1995).

    Article  Google Scholar 

  20. Bendich, A. & Machlin, L.J. Safety of oral intake of vitamin E. Am. J. Clin. Nutr. 48, 612–619 (1988).

    Article  CAS  Google Scholar 

  21. Sunderman, F.W. Therapeutic properties of sodium diethyldithiocarbamate: Its role as an inhibitor in the progression of AIDS. Ann. Clin. Lab. Sci. 21, 70–81 (1991).

    PubMed  Google Scholar 

  22. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G, cyclin-dependent kinases. Genes Dev. 9, 1149–1163 (1995).

    Article  CAS  Google Scholar 

  23. Gorospe, M., Wang, X., Guyton, K.Z. & Holbrook, N.J. Protective role of p21 (Waf 1 /Cip1) against prostaglandin A2-mediated apoptosis in human colorectal cancer cells. Mol. Cell. Biol. 16, 6654–6660 (1996).

    Article  CAS  Google Scholar 

  24. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. & Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945–1952 (1996).

    Article  CAS  Google Scholar 

  25. Wang, J. & Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359–361 (1996).

    Article  CAS  Google Scholar 

  26. Wu, G.S. & EI-Deiry, W.S. Apoptotic death of tumor cells correlates with chemosensitivity of p53 or Bcl-2. Clin. Cancer Res. 2, 623–633 (1996).

    CAS  PubMed  Google Scholar 

  27. Prahbu, N.S. et al. Suppression of cancer cell growth by adenovirus expressing p21WAF1/CIP1deficient in PCNA interaction. Clin. Cancer Res. 2, 1221–1230 (1996).

    Google Scholar 

  28. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J. & Howley, P.M. The E6 onco-protein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990).

    Article  CAS  Google Scholar 

  29. Kubbutat, M.H.G. & Vousden, K.H. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin. Viral. 7, 295–304 (1996).

    Article  CAS  Google Scholar 

  30. Waldman, T., Kinzler, K.W. & Vogelstein, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).

    CAS  Google Scholar 

  31. EI-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).

    Article  Google Scholar 

  32. Landschulz, W.H., Johnson, P.F., Adahi, E.Y., Graves, B.J. & McKnight, S.L. Isolation of a recombinant copy of the gene encoding C/EBP gene. Genes Dev, 2, 786–800 (1988).

    Article  CAS  Google Scholar 

  33. Akira, S. et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBOJ. 9, 1897–1906 (1990).

    Article  CAS  Google Scholar 

  34. Poli, V., Mancini, F.P. & Cortese, R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643–653 (1990).

    Article  CAS  Google Scholar 

  35. Cao, Z., Umek, R.M. & McKnight, S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538–1552 (1991).

    Article  CAS  Google Scholar 

  36. Williams, S.C., Cantwell, C.A. & Johnson, P.F. A family of C/EBP-related proteins capable of forming covalently linked leucine zippers dimers in vitro. Genes Dev. 5, 1553–1567 (1991).

    Article  CAS  Google Scholar 

  37. Akira, S. & Kishimot, T. IL-6 and NF-IL6 in acute-phase response to viral infection. Immunol. Rev. 127, 25–50 (1992).

    Article  CAS  Google Scholar 

  38. Timchenko, N.A., Wilde, M., Nakanishi, M., Smith, J.R. & Darlington, G.J. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1 /CIP-1 /SDI-1) protein. Genes Dev. 10, 804–815 (1996).

    Article  CAS  Google Scholar 

  39. Isshiki, H. et al. Constitutive and interleukin-1 (IL-l)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol. Cell. Biol. 10, 2757–2764 (1990).

    Article  CAS  Google Scholar 

  40. Vasseur-Cognet, M. & Lane, M.D. Trans-acting factors involved in adipogenic differentiation. Curr. Opin. Gen. Dev. 3, 238–245 (1993).

    Article  CAS  Google Scholar 

  41. Beg, A.A. & Baltimore, D. An essential role of NF-κB in preventing TNF—induced cell death. Science 274, 782–784 (1996).

    Article  CAS  Google Scholar 

  42. Wang, C.Y., Mayo, M.W. & Baldwin, A.S. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784–787 (1996).

    Article  CAS  Google Scholar 

  43. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R. & Verma, I.M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787–789 (1996).

    Article  CAS  Google Scholar 

  44. Grimm, S., Bauer-Manuel, K.A., Baeuerle, P.A. & Schulze, K.O. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell. Biol. 134, 13–23 (1996).

    Article  CAS  Google Scholar 

  45. Schreck, R., Grassmann, R., Fleckenstein, B. & Baeuerle, P.A. Antioxidants selectively suppress activation of NF-kappaB by human T-cell leukemia virus type I Tax protein. J. Virol. 66, 6288–6298 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Traenckner, E.B. et al. Phosphorylation of human I kappaB-alpha on serines 32 and 36 controls I kappaB-alpha proteolysis and NF-kappaB activation in response to diverse stimuli. EMBO J. 14, 2876–2883 (1995).

    Article  CAS  Google Scholar 

  47. Perkins, N.D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527 (1997).

    Article  CAS  Google Scholar 

  48. Harper, J.W., Hannon, G.J., Zhang, H., Casso, D. & Elledge, S.J. The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805–816 (1993).

    Article  CAS  Google Scholar 

  49. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701–704 (1993).

    Article  CAS  Google Scholar 

  50. Deng, C., Zhang, P., Harer, W.J., Elledge, S.J. & Leder, P. Mice lacking p21WAF1/CIP1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).

    Article  CAS  Google Scholar 

  51. Hunter, T. & Pines, J. Cyclins and cancer: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).

    Article  CAS  Google Scholar 

  52. Lemarie, E., Musset, M., Charbonnier, C., Renoux, M. & Renoux, G. Clinical characterization of Imuthipl. Methods Exp. Clin. Pharmacol. 8, 51–54 (1986).

    CAS  Google Scholar 

  53. Reisinger, E. et al. Inhibition of AIDS progression by dithiocarb. Lancet 335, 679–682 (1990).

    Article  CAS  Google Scholar 

  54. Danielson, P.E. et al. p1b15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7, 261–267 (1988).

    Article  CAS  Google Scholar 

  55. Kapiloff, M.S., Farkash, Y., Wegner, M. & Rosenfeld, M.G. Variable effects of phosphorylation of Pit-1 dictated by the DNA response elements. Science 253, 786–789 (1991).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert J. Coffey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chinery, R., Brockman, J., Peeler, M. et al. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ. Nat Med 3, 1233–1241 (1997). https://doi.org/10.1038/nm1197-1233

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1197-1233

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing